DALLAS, Feb. 18, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Vanda Pharmaceuticals Inc. (Nasdaq:VNDA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: http://www.stockpreacher.com/n/VNDA
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher
Vanda Pharmaceuticals Inc. (VNDA) is a biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with worldwide commercial rights to two product candidates in clinical development. The Company's product portfolio includes Iloperidone, a compound for the treatment of schizophrenia, and Tasimelteon, a compound for the treatment of sleep and mood disorders, including circadian rhythm sleep disorders (CRSD).
Message Board Search for VNDA: http://www.boardcentral.com/boards/VNDA
In the report, the analyst notes:
"VNDA reported a net loss of $9.2 million for the fourth quarter of 2009, compared to $7.7 million for the third quarter of 2009 and $7.5 million for the fourth quarter of 2008. Total revenue for the fourth quarter of 2009 was $4.5 million, consisting of $2.6 million in upfront licensing revenue and $1.9 million in product revenue for inventory sold to Novartis Pharma AG (Novartis). The remaining $197.4 million in deferred revenue relating to the $200.0 million upfront payment received from Novartis pursuant to the Fanapt(TM) (iloperidone) license agreement will be recognized ratably ($2.2 million per month) through May 2017.
"VNDA posted a wider-than-expected quarterly loss, hurt by expenses related to its deal with Novartis for its schizophrenia drug. For the fourth quarter, Vanda reported a net loss of $9.2 million, or 34 cents a share, compared with a loss of $7.5 million, or 28 cents a share, in the year-ago period."
To read the entire report visit: http://www.stockpreacher.com/n/VNDA
See what investors are saying about VNDA at penny stock forum
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors, LLC. StockPreacher.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.